This document contains a detailed protocol of the plaque reduction assays using human cell lines engineered to express CD4 and co-receptors for HIV and SIV entry. 1. The HIV-infected U87.CD4-CCR5 or –
Chimeric antigen receptors (CARs) are synthetic receptors that reprogram T cells to kill cancer. The success of CAR-T cell therapies highlights the promise of programmed immunity and suggests that a
